Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 17/20 | 0.47 |
| ▸ | CTSD | P07339 | 14/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7534011 | 1.00 | BACE1 (0.47) | BACE1CTSDEPHX1MAPTKDM4E | |
| SCHEMBL7534839 | 1.00 | BACE1 (0.47) | BACE1CTSDEPHX1MAPTKDM4E | |
| SCHEMBL8267582 | 1.00 | BACE1 (0.47) | BACE1CTSDEPHX1MAPTKDM4E | |
| SCHEMBL7533157 | 1.00 | BACE1 (0.47) | BACE1CTSDEPHX1MAPTKDM4E | |
| SCHEMBL7538661 | 1.00 | BACE1 (0.47) | BACE1CTSDEPHX1MAPTKDM4E | |
| SCHEMBL8289259 | 0.91 | BACE1 (0.51) | BACE1CTSDEPHX1 | |
| SCHEMBL7534015 | 0.91 | BACE1 (0.51) | BACE1CTSDEPHX1 | |
| SCHEMBL7533092 | 0.91 | BACE1 (0.51) | BACE1CTSDEPHX1 | |
| SCHEMBL7538348 | 0.91 | BACE1 (0.51) | BACE1CTSDEPHX1 | |
| SCHEMBL7538403 | 0.91 | BACE1 (0.51) | BACE1CTSDEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2343069-B1 | Heterocyclic aspartyl protease inhibitors | MERCK SHARP & DOHME (US) | 2016-03-02 | — | — | EP | disclosed |
| EP-2343069-A1 | Heterocyclic aspartyl protease inhibitors | Schering Corporation (US) | 2011-07-13 | — | — | EP | disclosed |
| EP-2335701-A1 | Heterocyclic aspartyl protease inhibitors | Schering Corporation (US) | 2011-06-22 | — | — | EP | disclosed |
| EP-2153832-A2 | Heterocyclic aspartyl protease inhibitors | SCHERING CORPORATION (US) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008103351-A2 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS | SCHERING CORPORATION (US) | 2008-08-28 | — | — | WO | disclosed |
| WO-2005058311-A1 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS | SCHERING CORPORATION (US) | 2005-06-30 | — | — | WO | disclosed |